LINC01486: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

Target Name: LINC01486

NCBI ID: G101928138

LINC01486

Other Name(s): long intergenic non-protein coding RNA 1486 | Long intergenic non-protein coding RNA 1486

LINC01486: A Long Intergenic Non-Protein-Coding RNA as a Drug Target or Biomarker

LINC01486 is a long non-coding RNA (lncRNA) that has been identified in various cellular and biological processes. It is expressed in various tissues and organs and is involved in various cellular processes, including cell growth, differentiation, and inflammation. LINC01486 has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, LINC01486 has potential as a drug target or biomarker.

Drug Target Potential

LINC01486 has been shown to be involved in various cellular signaling pathways that are involved in cancer development. For example, LINC01486 has been shown to be involved in the regulation of the NF-kappa pathway, which is a well-known regulator of cell growth and differentiation. LINC01486 has been shown to play a role in the regulation of NF-kappa signaling by binding to the NF-kappa receptor and preventing the activation of the receptor.

In addition to its role in NF-kappa signaling, LINC01486 has also been shown to be involved in the regulation of cell adhesion. Adhesion is a critical process that is involved in the formation and maintenance of tissues and organs, and is a key factor in the development and progression of various diseases, including cancer. LINC01486 has been shown to play a role in the regulation of cell adhesion by binding to the cadherin receptor, which is a protein that is involved in cell-cell adhesion.

Biomarker Potential

LINC01486 has also been shown to be involved in the regulation of various cellular processes that are involved in the development and progression of cancer. For example, LINC01486 has been shown to play a role in the regulation of the apoptosis pathway, which is a critical process that is involved in the elimination of damaged cells. LINC01486 has been shown to play a role in the regulation of apoptosis by binding to the B-cell lymphoma 1 (Bcl2) gene, which is a protein that is involved in the regulation of apoptosis.

In addition to its role in apoptosis, LINC01486 has also been shown to play a role in the regulation of cellular signaling pathways that are involved in cancer progression. For example, LINC01486 has been shown to play a role in the regulation of the PI3K/AKT signaling pathway, which is a critical pathway that is involved in the regulation of cellular signaling pathways that are involved in cancer progression.

Conclusion

In conclusion, LINC01486 is a long non-coding RNA that has been shown to play a role in various cellular and biological processes. Its potential as a drug target or biomarker makes it an attractive target for further research. Further studies are needed to fully understand the role of LINC01486 in cancer development and progression.

Protein Name: Long Intergenic Non-protein Coding RNA 1486

The "LINC01486 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01486 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets